Category: Include on Menu
-
Oruka Therapeutics Shares Jump 20% on Strong Phase 1 ORKA-001 Data
Oruka Therapeutics (NASDAQ:ORKA) saw its stock soar 20% on Tuesday following the release of promising interim results from its Phase 1 trial of ORKA-001, a long-acting IL-23p19 antibody for treating plaque psoriasis. The company reported that ORKA-001 demonstrated an approximate half-life of 100 days, more than three times longer than that of risankizumab, a competitor.…
-
Roivant Shares Jump on Positive Phase 3 Data for Dermatomyositis Therapy
Shares of Roivant Sciences (NASDAQ:ROIV) climbed 9% after the company, together with partner Priovant Therapeutics, reported encouraging Phase 3 results for brepocitinib in patients with dermatomyositis, a rare autoimmune disorder. The once-daily oral brepocitinib 30 mg showed statistically significant and clinically meaningful improvements versus placebo across the primary endpoint and all nine key secondary endpoints.…
-
Paramount Shares Drop Following Rithm Capital Acquisition Announcement
Paramount Group, Inc. (NYSE:PGRE) saw its stock fall sharply, tumbling 12% after revealing a definitive agreement to be acquired by Rithm Capital Corp. (NYSE:RITM) in an all-cash deal valued at around $1.6 billion. Under the terms, Rithm will purchase all outstanding Paramount shares at $6.60 per fully diluted share, representing a notable discount from the…
-
Regeneron’s Garetosmab Achieves Over 90% Reduction in Bone Lesions in FOP Study
Regeneron (NASDAQ:REGN) reported positive results from its Phase 3 Optima trial evaluating garetosmab in adults with fibrodysplasia ossificans progressiva (FOP), showing significant reductions in new bone formation. At the 56-week assessment, both dose levels outperformed placebo substantially. Patients receiving 3 mg/kg experienced a 94% decrease in new bone lesions, while those on the 10 mg/kg…
-
General Mills Tops Q1 Earnings Forecast Despite Sales Drop
General Mills, Inc. (NYSE:GIS) posted first-quarter fiscal 2026 results on Wednesday, surpassing analyst earnings expectations even as sales declined, and reaffirmed its full-year guidance. The company reported adjusted earnings of $0.86 per share, above the $0.81 consensus estimate, despite a 7% drop in net sales to $4.5 billion. Quarterly revenue of $4.52 billion met analyst…
-
New Fortress Energy Shares Surge on Long-Term Puerto Rico Gas Deal
Shares of New Fortress Energy Inc. (NASDAQ:NFE) jumped 23% in pre-market trading Wednesday following the announcement of a major long-term gas supply agreement with the Puerto Rican government. The company reached terms with Puerto Rico’s Third-Party Procurement Office and Public-Private Partnerships Authority for a seven-year liquefied natural gas (LNG) supply contract. The agreement is now…
-
UBS Predicts Silver Could Hit Record High as Investors Flock to Precious Metals
Silver has jumped to $42 an ounce, its highest level in 14 years, fueled by record-breaking gold prices and strong investment demand. Following this surge, UBS has upgraded its forecasts for the metal, projecting that silver could reach all-time highs within the next year. The bank now expects silver to trade at $44 an ounce…
-
Manchester United Shares Drop After Sixth Consecutive Annual Loss, Issues Soft Revenue Outlook
Manchester United (NYSE:MANU) on Wednesday revealed its sixth straight annual net loss, coupled with expectations of lower revenue in the current fiscal year, sending shares tumbling nearly 8% in premarket trading. The Premier League club reported a net loss of £33 million ($45 million) for the year ending June 30, an improvement from the £113.2…
-
Gemini Space Station Loses Steam After IPO as Investors Question Valuation
Shares of Gemini Space Station (NASDAQ:GEMI), the cryptocurrency exchange founded by Cameron and Tyler Winklevoss, were up 0.2% in pre-market trading on Wednesday, September 17, 2025, after closing 13.5% lower the previous day at $28.13. Since going public last Friday, the stock has already fallen nearly 24%, erasing much of the initial excitement. In its…
-
Forward Industries Files $4 Billion Program Focused on Solana
Forward Industries (NASDAQ:FORD), a Nasdaq-listed design company that has repositioned itself as a corporate treasury focused on Solana (COIN:SOLUSD), has filed a share offering program of up to $4 billion with the SEC. The at-the-market (ATM) program will allow the company to gradually sell shares depending on market conditions, through Cantor Fitzgerald. The company emphasized…